All News

Adding Ibrance to Imbruvica may be a promising treatment strategy for patients with mantle cell lymphoma, according to a recent study.

The Cancer Survivorship Symposium ended Saturday afternoon on a note of hope provided by survivor Wendy Harpham, M.D.

Despite recommendations to do so, distribution of survivorship care plans still has not increased for survivors of cancer, according to a recent study.

A recent study examined if the benefit from the drug brentuximab vedotin was worth the neuropathy that it causes for many patients with lymphoma.

Findings from a recent study lay out the groundwork to help identify men who are at higher risk from dying of prostate cancer.

Deborah K. Mayer recalls the breast cancer patient she counseled about treatment options.

It's my hope that two versions of the same story continue to be written because I am not ready to be the only storyteller.

Wanting to leave the world of cancer behind is a normal feeling for many touched by breast cancer.

The Life Raft Group, a patient advocacy organization, is teaming up with research organizations to hopefully find the next wave of treatment for patients with gastrointestinal stromal tumors.

As the needs of cancer survivors have been determined and researched, there is still confusion about which medical professional cares for what part of their survival.

CURE spoke with Neeraj Agarwal, M.D., about the underreporting and underemphasizing of toxicities with PD-1 inhibitors in renal cell carcinoma.

Vaccines are currently being tested in their potential to improve immunotherapy responses for patients with renal cell carcinoma.

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

New research will be presented this weekend at the Cancer Survivorship Symposium: Advancing Care and Research.

Long before my own cancer diagnosis I received this life-changing lesson in courage

Sometimes I lose weight and sometimes I lose inches, but does it matter?

A recent phase 3 trial showed that treatment with Lenvima is noninferior to standard treatment for patients with unresectable liver cancer.

Many partners and caregivers still feel anxious years after their loved one's diagnosis, according to a recent study.

Actress, author, cancer survivor and advocate Fran Drescher offers tips to help detoxify homes and build a healthier environment.

When I heard the expression "Leave it all on the floor," I decided to put those words to use.

Breast cancer survivor says a cancer diagnosis is a shocking experience, and shares help to cope with it.

Though now used for patients with grade 4 brain tumors, tumor treating fields are being tested for use in grade 3 tumors.

Elizabeth Plimack, M.D., discusses an update on the CheckMate-025 trial, comparing Opdivo to Afinitor in patients with metastatic renal cell carcinoma.

Amy Herman offers tips to increase visual intelligence, and how that can be helpful for patients with cancer.

Opdivo is showing benefit for patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC), according to a recent trial.

NFL Hall of Famer Jim Kelly discusses how cancer touched his family and his involvement in Your Cancer Game Plan.

A cancer survivor’s hottest commodity is time. Here's how I've created more time while also reducing anxiety and being happier.